Oral topical doxepin rinse: Anesthetic effect in normal subjects

Pain Research and Management

Volumn 8, Issue 4, 2003, Pages 195-197

  Epstein, Joel B ^a,b,d   Truelove, Edmond L ^c   Oien, Hal ^d   Le, Nhu D ^a   Epstein, Mathew S ^e  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d British Columbia Cancer Agency ^*  (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Doxepin; Topical analgesia; Topical anesthetic

Indexed keywords

DOXEPIN; ANESTHETIC AGENT;

ANALGESIA; ANESTHESIA; ARTICLE; CLINICAL ARTICLE; FATIGUE; HUMAN; ORAL MUCOSAL DISEASE; PARESTHESIA; SEDATION; ADOLESCENT; ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; MALE; MIDDLE AGED; MOUTH MUCOSA; PAIN; PAIN ASSESSMENT; PATHOLOGY; TIME;

ADOLESCENT; ADULT; ANESTHETICS; DOXEPIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; PAIN; PAIN MEASUREMENT; TIME FACTORS;

EID: 2142758169     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/431308     Document Type: Article

References (17)

1. Tollison CD, Kriegel ML. Selected tricyclic antidepressants in the management of chronic benign pain. South Med J 1988;81:562-4.
2. Medical Economics Comany, Hogan RW. The Pdr Family Guide to Prescription Drugs. New York: Three Rivers Press, 1998.
3. Hameroff SR, Cork RC, Scherer K, et al. Doxepin effects on chronic pain, depression and plasma opioids. J Clin Psychiatry 1982;43:22-7.
4. Kiefer G, Fischer W, Feuerstein TJ. Effects of amitriptyline, amitriptylinoxide, doxepin and clozapine on N-methyl-D-aspartate-evoked release of (3H)-acetylcholine in rat caudatoputamen. Arzneimittelforschung 1999;49:820-3.
5. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: A randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000;49:574-9.
6. Richeimer SH, Bajwa ZH, Kahraman SS, Ransil BJ, Warfield CA. Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: A survey. Clin J Pain 1997;13:324-9.
7. Cohn ML, Machado AF, Bier R, Cohn M. Piroxicam and doxepin - an alternative to narcotic analgesics in managing advanced cancer pain. West J Med 1988;148:303-6.
8. Salem RB, Fischer RG, Beghe C. Acute stomatitis associated with doxepin therapy. Drug Intell Clin Pharm 1981;15:992-3.
9. McLean GJ. Topical doxepin hydrochloride reduces neuropathic pain: A randomized, double-blind, placebo controlled study. The Pain Clinic 2000;2:47-50.
10. Sonis ST, Eilers JP, Epstein JB, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer 1999;85:2103-13.
11. Epstein JB, Truelove EL, Oien H, Allison C, Epstein MS. Oral topical doxepin rinse: Analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. Oral Oncol 2001;37:632-7.
12. Epstein JB, Schubert MM. Management of orofacial pain in cancer patients. Eur J Cancer Oral Oncol 1993;29B:243-50.
13. Kramp LF, Eleazer PD, Scheetz JP. Evaluation of prilocaine for the reduction of pain associated with transmucosal anesthetic administration. Anesth Prog 1999;46:52-5.
14. Ameer B, Burlingame MB, Harman EM. Rapid mucosal absorption of topical lidocaine during bronchoscopy in the presence of oral candidiasis. Chest 1989;96:1438-9.
15. Elad S, Cohen G, Zylber-Katz E, et al. Systemic absorption of lidocaine after topical application for the treatment of oral mucositis in bone marrow transplantation patients. J Oral Pathol Med 1999;28:170-2.
16. Epstein JB, Stevenson-Moore P, Jackson SM, Mohamed JH, Spinelli JJ. Prevention of oral mucositis in radiation therapy: A controlled study with benzydamine hydrochloride rinse. Int J Radiat Oncol Biol Phys 1989;16:1571-5.
17. Berberian BJ, Breneman DL, Drake LA, et al. The addition of topical doxepin to corticosteroid therapy: An improved treatment regimen for atopic dermatitis. Int J Dermatol 1999;38:145-8.